PI
NEO icon

Putnam Investments’s NeoGenomics NEO Stock Holding History

Putnam Investments’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$11.3M Buy
699,432
+331,853
+90% +$5.43M 0.01% 307
2023
Q3 		$4.52M Buy
+367,579
New +$5.47M 0.01% 452

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Putnam Investments's NEO Position: Q4 2023 in Review

Putnam Investments increased its NeoGenomics (NEO) stake by 90% in Q4 2023, buying an estimated $5.43M and bringing the position to 699,432 shares worth $11.3M. The position accounts for 0.01% of the portfolio, ranked #307.

Putnam Investments first reported a position in NEO in Q3 2023 and has held it in 2 quarters since. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.

  • Putnam Investments held 699,432 shares of NeoGenomics worth $11.3M as of Q4 2023.
  • Putnam Investments bought 331,853 NeoGenomics shares in Q4 2023, an estimated $5.43M.
  • NeoGenomics made up 0.01% of Putnam Investments's portfolio in Q4 2023, its #307 holding.
  • Putnam Investments first reported a position in NeoGenomics in Q3 2023 and has held it in 2 quarters since.
  • 287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.